healthcare
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall...
Published:
A recent analysis reveals that all the rural hospitals in Connecticut are at risk of closing.
Published:
Here are a few big biopharma names on which Wall Street is growing more bearish.
Published:
A recent analysis reveals which states have the longest average ER waiting times.
Published:
A recent analysis reveals which types of doctors are most likely to report burnout.
Published:
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and...
Published:
A few big biopharma names were on the move Tuesday morning, and analysts were taking their shot at them.
Published:
A recent analysis reveals that a drug discount program can save consumers up to $6,100 off the retail price.
Published:
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Published:
A recent analysis reveals that Louisiana is the least healthy state in America.
Published:
Now is the time to reduce risk and more to safer ideas. Top-quality health care stocks may be the way to go for the rest of 2021 and in 2022, and these five Dividend Aristocrats make good sense now...
Published:
Last Updated:
Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets, attractive dividend yields and improved cost structures. With even moderate...
Published:
While not suited for conservative income investors, these two top biotech stocks could have huge total return potential and offer investors with a touch more risk tolerance some very tempting entry...
Published:
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.
Published:
Pot grower Tilray is acquiring a majority position in U.S.-based cannabis retailer MedMen. Is this a portent of more consolidation in the industry?
Published: